Paralog-Specific Kinase Inhibition of FGFR4: Adding to the Arsenal of Anti-FGFR Agents

Han Kiat Ho, Angie Hui Ling Yeo, Tse Siang Kang, Boon Tin Chua, Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerations Drug Discovery Today. ,vol. 19, pp. 51- 62 ,(2014) , 10.1016/J.DRUDIS.2013.07.021

Corentin Herbert, Gilbert Lassalle, Chantal Alcouffe, Françoise Bono, Approaches targeting the FGF–FGFR system: a review of the recent patent literature and associated advanced therapeutic agents Pharmaceutical patent analyst. ,vol. 3, pp. 585- 612 ,(2014) , 10.4155/PPA.14.45

Dalbir S. Sandhu, Esha Baichoo, Lewis R. Roberts, Fibroblast growth factor signaling in liver carcinogenesis Hepatology. ,vol. 59, pp. 1166- 1173 ,(2014) , 10.1002/HEP.26679

Eric T. Sawey, Maia Chanrion, Chunlin Cai, Guanming Wu, Jianping Zhang, Lars Zender, Alice Zhao, Ronald W. Busuttil, Herman Yee, Lincoln Stein, Dorothy M. French, Richard S. Finn, Scott W. Lowe, Scott Powers, Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening Cancer Cell. ,vol. 19, pp. 347- 358 ,(2011) , 10.1016/J.CCR.2011.01.040

Li Tan, Jun Wang, Junko Tanizaki, Zhifeng Huang, Amir R. Aref, Maria Rusan, Su-Jie Zhu, Yiyun Zhang, Dalia Ercan, Rachel G. Liao, Marzia Capelletti, Wenjun Zhou, Wooyoung Hur, NamDoo Kim, Taebo Sim, Suzanne Gaudet, David A. Barbie, Jing-Ruey Joanna Yeh, Cai-Hong Yun, Peter S. Hammerman, Moosa Mohammadi, Pasi A. Jänne, Nathanael S. Gray, Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 111, ,(2014) , 10.1073/PNAS.1403438111

Christine Heinzle, Zeynep Erdem, Jakob Paur, Bettina Grasl-Kraupp, Klaus Holzmann, Michael Grusch, Walter Berger, Brigitte Marian, Is fibroblast growth factor receptor 4 a suitable target of cancer therapy Current Pharmaceutical Design. ,vol. 20, pp. 2881- 2898 ,(2014) , 10.2174/13816128113199990594

Vito Guagnano, Audrey Kauffmann, Simon Wöhrle, Christelle Stamm, Moriko Ito, Louise Barys, Astrid Pornon, Yao Yao, Fang Li, Yun Zhang, Zhi Chen, Christopher J. Wilson, Vincent Bordas, Mickaël Le Douget, L. Alex Gaither, Jason Borawski, John E. Monahan, Kavitha Venkatesan, Thomas Brümmendorf, David M. Thomas, Carlos Garcia-Echeverria, Francesco Hofmann, William R. Sellers, Diana Graus-Porta, FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor Cancer Discovery. ,vol. 2, pp. 1118- 1133 ,(2012) , 10.1158/2159-8290.CD-12-0210

Margit Hagel, Chandra Miduturu, Michael Sheets, Nooreen Rubin, Weifan Weng, Nicolas Stransky, Neil Bifulco, Joseph L. Kim, Brian Hodous, Natasja Brooijmans, Adam Shutes, Christopher Winter, Christoph Lengauer, Nancy E. Kohl, Timothy Guzi, First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway Cancer Discovery. ,vol. 5, pp. 424- 437 ,(2015) , 10.1158/2159-8290.CD-14-1029

Mei Zhou, Xueyan Wang, Van Phung, Darrin A. Lindhout, Kalyani Mondal, Jer-Yuan Hsu, Hong Yang, Mark Humphrey, Xunshan Ding, Taruna Arora, R. Marc Learned, Alex M. DePaoli, Hui Tian, Lei Ling, Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19 Cancer Research. ,vol. 74, pp. 3306- 3316 ,(2014) , 10.1158/0008-5472.CAN-14-0208

Rama Pai, Dorothy French, Ning Ma, Kathy Hotzel, Emile Plise, Laurent Salphati, Kenneth D. R. Setchell, Joseph Ware, Veronique Lauriault, Leah Schutt, Dylan Hartley, Donna Dambach, Antibody-Mediated Inhibition of Fibroblast Growth Factor 19 Results in Increased Bile Acids Synthesis and Ileal Malabsorption of Bile Acids in Cynomolgus Monkeys Toxicological Sciences. ,vol. 126, pp. 446- 456 ,(2012) , 10.1093/TOXSCI/KFS011